Search

Bio Roundup: CMS Backs Cancer Tests, Right to Try Passes, AbbVie Sinks

BIO ROUNDUP: CMS BACKS CANCER TESTS, RIGHT TO TRY PASSES, ABBVIE SINKS

We'll start this week's roundup with several stories from Washington, D.C. that could have a lasting effect on public health. The FDA...

Halozyme Inks $105M Bristol-Myers Partnership, Expands Roche Deal

HALOZYME INKS $105M BRISTOL-MYERS PARTNERSHIP, EXPANDS ROCHE DEAL

Halozyme Therapeutics has turned a method of delivering a drug more conveniently into partnerships with several large pharmaceutical...